Preview

Ophthalmology in Russia

Advanced search

Optimization of Transscleral Laser Cyclothermotherapy Method (experimental study)

https://doi.org/10.18008/1816-5095-2026-1-195-198

Abstract

Objectives: to evaluate the feasibility of reducing exposure time during transscleral laser cyclothermotherapy (TLCTT) by applying a pulsedperiodic laser mode in an experimental setting. 

Methods. The study was conducted on Chinchilla rabbits of both sexes, weighing 1.5–2.0 kg. Animals were divided into two groups. The control group (20 rabbits, 40 eyes) underwent TLCTT using a continuous laser mode (0.3 W, 16 s). The experimental group (10 rabbits, 20 eyes) received TLCTT with a pulsed-periodic laser mode (duty cycle 50 %, pulse period 1 s), at 0.6 W for 8 s. Biomicroscopy was performed one day after the procedure to evaluate inflammatory response, and macroscopic examination of ciliary body specimens was carried out to assess the characteristics of destruction foci. 

Results. Biomicroscopy revealed mixed conjunctival injection in all animals, with moderate chemosis in 45 % of eyes in the control group and 50 % in the experimental group. Aqueous humor opalescence of moderate intensity was noted in 75 % and 80 % of eyes, respectively. No precipitates, posterior synechiae, or fibrinous deposits were observed. Macroscopically, destruction foci appeared as pale areas of ciliary processes with comparable diameters (1.35 ± 0.07 mm in the control group and 1.34 ± 0.08 mm in the experimental group, = 0.3). No rupture-associated mechanical effects were detected in either group. 

Conclusion. The pulsed-periodic laser mode achieved destruction foci of comparable size to conventional TLCTT, without inducing additional mechanical damage or excessive postoperative inflammation. The shortened exposure time reduces the risk of light guide displacement during the procedure, potentially improving both safety and effectiveness.

About the Authors

V. Yu. Skvortsov
S.M. Kirov Military Medical Academy
Russian Federation

Skvortsov Vyacheslav Yu., PhD, lecturer, Department of Ophthalmology 

Akademician Lebedev str., 6zh, Saint Petersburg, 194044



A. N. Kulikov
S.M. Kirov Military Medical Academy
Russian Federation

Kulikov Alexey N., MD, Professor, head of the Department and Clinic of Ophthalmology 

Akademician Lebedev str., 6zh, Saint Petersburg, 194044



D. V. Tulin
S.M. Kirov Military Medical Academy
Russian Federation

Tulin Dmitry V., ophthalmologist, Clinic of Ophthalmology

Akademician Lebedev str., 6zh, Saint Petersburg, 194044



References

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268–1279. doi: 10.1001/archopht.120.10.1268.

2. Boland MV, Ervin AM, Friedman DS, Jampel HD, Hawkins BS, Vollenweider D, Chelladurai Y, Ward D, Suarez-Cuervo C, Robinson KA. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Feb 19;158(4):271–279. doi: 10.7326/0003-4819-158-4-201302190-00008.

3. Gaasterland DE, Pollack IP. Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma. Trans Am Ophthalmol Soc. 1992;90:225–243; discussion 243–246. https://pmc.ncbi.nlm.nih.gov/articles/PMC1298436/.

4. Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2007 Dec;91(12):1631–1635. doi: 10.1136/bjo.2007.116533.

5. Seixas RCS, Russ HHA, Maestrini HA, Balbino M, Fernandes TAP, Lima NVDA, Lopes NLV, Neto TDSR. Slow coagulation versus micropulse transscleral cyclophotocoagulation for refractory childhood glaucoma. Eur J Ophthalmol. 2024 Nov;34(6):1932–1940. doi: 10.1177/11206721241236920.

6. Agrawal P, Dulku S, Nolan W, Sung V. The UK National Cyclodiode Laser Survey. Eye (Lond). 2011 Feb;25(2):168–173. doi: 10.1038/eye.2010.174.

7. Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NS, Hitchings RA, Khaw PT. “Cyclodiode”. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. 1997 Sep;104(9):1508–1519; discussion 1519–1520. doi: 10.1016/s0161-6420(97)30109-2.

8. Ndulue JK, Rahmatnejad K, Sanvicente C, Wizov SS, Moster MR. Evolution of Cyclophotocoagulation. J Ophthalmic Vis Res. 2018 Jan-Mar;13(1):55–61. doi: 10.4103/jovr.jovr_190_17.

9. Boĭko ÉV, Kulikov AN, Skvortsov VIu. Evaluating the effectiveness and safety of diode laser trans-scleral thermotherapy of the ciliary body as a treatment for refractory glaucoma. Russian Annals of Ophthalmology. 2014;130(5):64–66 (In Russ.). https://www.mediasphera.ru/issues/vestnik-oftalmologii/2014/5/030042465X2014511 (аccessed 15.09.2025).

10. Boĭko ÉV, Kulikov AN, Skvortsov VIu. Comparative evaluation of diode laser thermotherapy and laser coagulation as methods of cyclodestruction (experimental study). Practical medicine. 2012;4:175–179 (In Russ.). https://pmarchive.ru/sravnitelnaya-ocenka-diod-lazernoj-termoterapii-i-lazerokoagulyacii-kak-metodov-ciklodestrukcii-eksperimentalnoe-issledovanie/(аccessed 15.09.2025).


Review

For citations:


Skvortsov V.Yu., Kulikov A.N., Tulin D.V. Optimization of Transscleral Laser Cyclothermotherapy Method (experimental study). Ophthalmology in Russia. 2026;23(1):195-198. (In Russ.) https://doi.org/10.18008/1816-5095-2026-1-195-198

Views: 194

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)